![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhUEZUmpP4dhwPBwUEt_rW8HIPogrK97b9GWHVg3RoxvgZ4RQvYFx-TZn9prVKoKE-l28gqSFhJD1GoOCZR-BOKJUzhdkcUO730IQ8USqDed_DeuGfhSQwg_42ZgYsKrZu4gdkXJ9cPQIw/s320/fdagov_logo_type.gif)
Postmarket Reviews - Volume 2, Number 2, 2009
Back to Table of Contents
- Quinine Sulfate (Marketed as Qualaquin): Off-Label (Not Approved by FDA) Use of Quininess
-- Zolendronic Acid (Marketed as Reclast): Renal Impairment and Acute Liver Failure
--- Arginine Hydrochloride Injection (Marketed as R-Gene 10): Fatal Medication Errors in a Pediatric Population
abrir aquí para acceder a los documentos (idioma inglés únicamente):
Postmarket Reviews - Volume 2, Number 2, 2009
No hay comentarios:
Publicar un comentario